GGrantIndex
← Search

Pharmaceutical Research Center Shared Resource

$3,293P30FY2018CANIH

University Of Wisconsin-Madison, Madison WI

Investigators

Linked publications, trials & patents

Paper 39638850Paper 39604703Paper 39580301Paper 39530524Paper 39527745Paper 39516197Paper 39484544Paper 39481346Paper 39474803Paper 39462136Paper 39452931Paper 39444276Paper 39443360Paper 39432401Paper 39414902Paper 39408582Paper 39407431Paper 39402986Paper 39399121Paper 39386576Paper 39386545Paper 39379374Paper 39374311Paper 39364328Paper 39358429Paper 39345631Paper 39335130Paper 39312186Trial NCT06608511Trial NCT06557733Trial NCT05985681Trial NCT05521698Trial NCT05107219Trial NCT03725761Trial NCT03722030Trial NCT03703492Trial NCT03656276Trial NCT03393741Trial NCT03387514Trial NCT03358563Trial NCT03356470Trial NCT03342378Trial NCT03304002Trial NCT03300557Trial NCT03209869Trial NCT03185871Trial NCT03028584Trial NCT03023202Trial NCT02955043Trial NCT02917629Trial NCT02876640Trial NCT02780401Trial NCT02719821Trial NCT02169284Trial NCT02096783Trial NCT02095145Trial NCT01999881Trial NCT01935960Trial NCT01901835Trial NCT01707004Trial NCT01625156Trial NCT01325311Trial NCT01263613Trial NCT01245205Trial NCT01243359Trial NCT01233505Trial NCT01218620Trial NCT01217450Trial NCT01158274Trial NCT01083641Trial NCT01004796Trial NCT00896974Trial NCT00666562Trial NCT00544596Trial NCT00499135Trial NCT00462969Trial NCT00415025Trial NCT00410605Trial NCT00227513Trial NCT00138203Trial NCT00109863Trial NCT00079014Trial NCT00052832Trial NCT00049712Trial NCT00036790Trial NCT00028652Trial NCT00023855Trial NCT00022412Trial NCT00005794Trial NCT00004872Patent 9867974Patent 9763597Patent 9603567Patent 9470697Patent 9161720Patent 8871458Patent 6974254Patent 6438202Patent 6114119Patent 6020178

Abstract

PROJECT SUMMARY/ABSTRACT The Pharmaceutical Research Center (PRC) operates within the University of Wisconsin Health System (UW Health) and is responsible for the safe and ethical provision of investigational study medications to research subjects enrolled in all clinical drug trials within our hospitals and clinics, including those of The University of Wisconsin Carbone Cancer Center (UWCCC). The mission of the PRC is to ensure that drug research protocols proceed optimally through established medication use systems and in accordance with all federal, state, institutional, and sponsor regulations governing clinical research. PRC services enhance regulatory rigor and subject safety while facilitating the conduct of clinical drug research within our academic medical center. For each clinical drug trial, PRC establishes study drug handling, distribution, preparation, and destruction procedures; develops a protocol specific workflow; creates an investigational drug monograph(s) for health care providers; educates health care staff regarding protocol procedures; creates the physician orders set; manages drug inventory and accountability; prepares drugs and/or monitors drug preparation; monitors drug expiration and retest dates; provides quality assurance audits; and reviews all protocol amendments. In addition, PRC provides services that are specifically tailored to the unique needs of UWCCC investigators. For example, PRC manages trials involving gene therapy and hazardous oncology drugs; provides accurate response to drug interaction inquiries from investigators and care providers; and verifies authorized prescriber status in accordance with NCI requirements. During the current CCSG funding cycle, PRC has enabled UWCCC investigators to implement 170 peer-reviewed clinical drug trials and has provided study drug oversight for an average of 200 cancer focused clinical trials each year. PRC strives to refine, enhance and/or expand our services to meet the evolving needs of the UWCCC research faculty and our research subjects, while operating in rapidly changing healthcare and regulatory environments. Our specific aims are to: 1) provide detailed protocol review and feasibility assessment of each UWCCC protocol; 2) ensure all UWCCC study protocols comply with Good Clinical Practice (GCP) standards; 3) provide services essential to the advancement of clinical cancer research; and 4) facilitate clinical drug research within UW Health satellite pharmacies that extend clinical cancer research across our catchment area. Base funding from the CCSG allows PRC leaders to serve as members of the UWCCC scientific leadership team to ensure PRC is well positioned to meet the evolving needs of UWCCC investigators and thereby enhance the ability of our members to enroll patients onto investigator initiated clinical studies that ultimately will improve outcomes for our patients and society.

View original record on NIH RePORTER →